| 引用本文:李小科，叶永安，杜宏波.基于2015年版慢性乙型肝炎防治指南谈中医药治疗的机遇与挑战[J].世界中医药,2016,(02):. |
|
| 基于2015年版慢性乙型肝炎防治指南谈中医药治疗的机遇与挑战 |
| Challenges and Opportunities Met by TCM Treatment for Chronic Hepatitis B: Based on 2015 Prevention and Cure Guidelines of the Disease |
| 投稿时间：2016-01-29 |
| DOI：10.3969/j.issn.1673-7202.2016.02.048 |
| 中文关键词: 慢性乙型肝炎 防治指南 中医药 |
| English Keywords:Chronic Hepatitis B Prevention and Cure Guidelines Traditional Chinese medicine |
| 基金项目:国家科技重大专项（重大传染病防治）课题“慢性病毒性肝炎中西医结合治疗方案优化研究”（编号：2012ZX10005004） |
|
| 摘要点击次数: 1001 |
| 全文下载次数: 1289 |
| 中文摘要: |
| 2015年，包括WHO，APASL，AASLD及我国学术组织均颁布了针对慢性乙型肝炎最新的防治指南，结合更新的临床证据对慢性乙型肝炎规范化治疗给予指导。中医药是我国医药卫生资源的独特优势，在本次指南的更新中，包括我国指南在内，各指南均未对中医药疗法（包括其他辅助或替代疗法）的作用进行明确评价。文章通过对各指南在防治目标、治疗终点、目标人群、停药时机等方面的意见进行比较，并分别结合中医药治疗自身优势进行分析，对该病的治疗中如何发挥中医特色优势进行讨论。 |
| English Summary: |
| In the year of 2015, WHO, APASL, AASLD and some academic organizations in China updated the Prevention and Cure Guidelines of Chronic Hepatitis B(CHB), so as to provide standard guidance to CHB treatment based on the latest clinical evidence. Traditional Chinese Medicine (TCM) has inherent advantage in China’s medical care, however, none of the new guidelines evaluated the efficacy of TCM treatment (or any other complementary therapies) for CHB. In this article, the potential advantages and applications of TCM treatment for CHB were discussed by comparing views of the guidelines in the aspects of treating goals, clinical end points, target populations and discontinuation time etc. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
